Arbutus Biopharma Files 8-K on Operations and Personnel
Ticker: ABUS · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1447028
| Field | Detail |
|---|---|
| Company | Arbutus Biopharma Corp (ABUS) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, personnel, filing
TL;DR
Arbutus Biopharma dropped an 8-K covering financials, ops, and exec changes. Check it out.
AI Summary
Arbutus Biopharma Corporation filed an 8-K on August 6, 2025, reporting on events as of August 4, 2025. The filing covers results of operations and financial condition, director and officer changes, other events, and financial statements. The company was formerly known as Tekmira Pharmaceuticals Corp.
Why It Matters
This 8-K filing provides updates on Arbutus Biopharma's operational and financial status, as well as any significant changes in its leadership or board of directors.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting on operational and personnel matters, not indicating immediate financial distress or significant new risks.
Key Players & Entities
- Arbutus Biopharma Corporation (company) — Registrant
- Tekmira Pharmaceuticals Corp (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for Arbutus Biopharma Corporation?
The primary purpose is to report on the company's results of operations and financial condition, departure/election of directors or officers, other events, and financial statements as of August 4, 2025.
When was this 8-K report filed with the SEC?
This 8-K report was filed on August 6, 2025.
What was Arbutus Biopharma Corporation's former name?
Arbutus Biopharma Corporation was formerly known as Tekmira Pharmaceuticals Corp.
What is the SIC code for Arbutus Biopharma Corporation?
The Standard Industrial Classification (SIC) code for Arbutus Biopharma Corporation is 2834, which corresponds to Pharmaceutical Preparations.
Where is Arbutus Biopharma Corporation headquartered?
Arbutus Biopharma Corporation's business and mailing address is 701 Veterans Circle, Warminster, PA 18974.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding Arbutus Biopharma Corp (ABUS).